The defect in XLA resides in Bruton tyrosine kinase (BTK), also known as B cell progenitor kinase (BPK) or agammaglobulinemia tyrosine kinase (ATK), a key regulator in B-cell development (7). Here, BTK is linked to Bruton-type agammaglobulinemia.